Samuel W Brady

13PUBLICATIONS
136CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 29, 2026
IRS4 is a PI3K-activating cancer dependency up-regulated through DNA rearrangements or epigenetic mechanisms in multiple solid tumors.

|Apr 19, 2026
Therapy-Related Mutational Signatures in Subsequent Neoplasms among Survivors of Childhood Cancer.

|Sep 10, 2025
Somatic mtDNA mutations at intermediate levels of heteroplasmy are a source of functional heterogeneity among primary leukemic cells.

Kelly McCastlain, Catherine Welsh, Yonghui Ni

|May 13, 2025
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia.

Ruth W Wang'ondu, Emily Ashcraft, Ti-Cheng Chang

|Jan 29, 2025
Molecular and pharmacological heterogeneity of ETV6::RUNX1 acute lymphoblastic leukemia.

Zhenhua Li, Huanbin Zhao, Wenjian Yang

|Nov 28, 2024
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia.

Charles Mullighan, Ruth Wangondu, Emily Ashcraft

Pageof 3

Frequent Collaborators

6 joint publications

Gang Wu

6 joint publications

Jinghui Zhang

5 joint publications

Charles Mullighan

5 joint publications

Xiaotu Ma